Gabapentin Add-on for Drug-Resistant Partial Epilepsy.
Gabapentin add-on for drug-resistant partial epilepsy.
Cochrane Database Syst Rev. 2013 Jul 25; 7: CD001415
Al-Bachari S, Pulman J, Hutton JL, Marson AG
The majority of people with epilepsy have a good prognosis and their seizures are well controlled… Continue reading
Current and Emerging Treatments for Absence Seizures in Young Patients.
Current and emerging treatments for absence seizures in young patients.
Neuropsychiatr Dis Treat. 2013; 9: 963-75
Vrielynck P
In this report, we review the pharmacological and non-pharmacological treatments of the different absence seizure types as recently recognized by the… Continue reading
Preliminarily Analysis of Carbamazepine (CBZ) C0 in Patients Visited Isfahan Epileptic Clinics.
Preliminarily Analysis of Carbamazepine (CBZ) C0 in Patients Visited Isfahan Epileptic Clinics.
Int J Prev Med. 2013 May; 4(Suppl 2): S343-6
Tolou-Ghamari Z, Najafi MR, Habibabadi JM, Zare M
Carbamazepine (CBZ) is mostly considered as the first line of… Continue reading
Corticomuscular Coherence Analysis on Hand Movement Distinction for Active Rehabilitation.
Corticomuscular Coherence Analysis on Hand Movement Distinction for Active Rehabilitation.
Comput Math Methods Med. 2013; 2013: 908591
Lou X, Xiao S, Qi Y, Hu X, Wang Y, Zheng X
Active rehabilitation involves patient’s voluntary thoughts as the control signals… Continue reading
Update on the Treatment of Non-Small-Cell Lung Cancer: Focus on the Cost-Effectiveness of New Agents.
Update on the treatment of non-small-cell lung cancer: focus on the cost-effectiveness of new agents.
Clinicoecon Outcomes Res. 2013; 5: 137-41
Vergnenègre A, Borget I, Chouaid C
The incidence of lung cancer and the cost of drug treatment have… Continue reading